Revolution Medicines Affiliate Lorence H. Kim Files Form 144 for $15.19M Planned Stock Sale
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Company: Revolution Medicines, Inc. ($RVMD) Insider: Lorence H Kim (Affiliate) Proposed Sale Date: August 31, 2026 Shares to Sell: 73,090 Estimated Total Value: $15,193,949.20 Broker: J.P. Morgan Securities LLC Trading Plan: Adopted June 1, 2026 (Rule 10b5-1)
Comprehensive Analysis
Executive Summary
On August 31, 2026, Lorence H. Kim, an affiliate of Revolution Medicines, Inc. (RVMD), filed a Form 144 notice proposing the sale of 73,090 shares of common stock with an aggregate market value of approximately $15.19 million.
Transaction & Plan Details
- Security: Common Stock
- Number of Shares: 73,090
- Aggregate Market Value: $15,193,949.20 (~$207.88 per share implied)
- Shares Outstanding: 214,336,418 shares (~0.034% of outstanding common stock)
- Broker: J.P. Morgan Securities LLC
- Trading Plan: The proposed transactions are executed pursuant to a Rule 10b5-1 trading plan adopted on June 1, 2026.
- Ownership Entity: The shares are being sold by the Kim Revocable Trust, Lorence H. Kim, as Trustee.
Origin of Securities
- 50,000 shares acquired via open market purchase on July 20, 2022.
- 23,090 shares acquired via multiple RSU vestings between December 15, 2022, and June 26, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.